Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
9141por Sundaresan, Yogapriya, Manivannan, Lakshmi Priya, Radhakrishnan, Shanthi, Ramasamy, Krishnadas Subbiah, Veerappan, Muthukkaruppan, Chidambaranathan, Gowri Priya“…Analysis of hematoxylin and eosin-stained sections from glaucomatous tissues revealed a decrease in total TM cellularity, thickening of trabecular beams, fusion of trabeculae, absence of patent Schlemm’s canal compared to age-matched controls. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9142por Al-Anzi, Fawaz S.“…This study illustrates how the proposed Value Engineering-based model became the foremost baseline method for developing a new innovative model to reduce cost and patentable design.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9143por Nath, Lekshmi R., Swetha, Mundanattu, Vijayakurup, Vinod, Thangarasu, Arun Kumar, Haritha, Nair Hariprasad, Shabna, Anwar, Aiswarya, Sreekumar U., Rayginia, Tennyson P., Keerthana, C. K., Kalimuthu, Kalishwaralal, Sundaram, Sankar, Lankalapalli, Ravi Shankar, Pillai, Sreekumar, Towner, Rheal, Isakov, Noah, Anto, Ruby John“…Our innovation has been granted a patent from the US (US 2019/0160088A1), Canada (3,026,426.), Japan (JP2019520425) and South Korea (KR1020190008323) and the technology have been transferred commercially to Q Biomed, a leading US-based Biotech company. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9144“…Repeat angiography at 3 months showed patent stents with TIMI III flow, and optical coherence tomography (OCT) showed good expansion and apposition of the proximal Absorb BVS and BeGraft. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9145por Leonhardt, Henrik, Thilander-Klang, Anne, Båth, John, Johannesson, Marit, Kvarnström, Niclas, Dahm-Kähler, Pernilla, Brännström, Mats“…MRA was not able to fully evaluate 10 (43%) out of 23 UA that proved to be patent on DSA. One UA was not identified by any of the modalities, and three MRA-absent UAs were identified by both CTA and DSA. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9146por Restrepo-Montoya, Daniel, Hulse-Kemp, Amanda M., Scheffler, Jodi A., Haigler, Candace H., Hinze, Lori L., Love, Janna, Percy, Richard G., Jones, Don C., Frelichowski, James“…However, qualitative descriptors are useful in cataloging germplasm collections and for describing new germplasm in patents, publications, and/or the Plant Variety Protection (PVP) system. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9147por Bae, Sohyun, Kim, Yoonjung, Chang, Hyun-Ha, Kim, Sungjin, Kim, Hyun-Ji, Jeon, Hyeyoung, Cho, Juhee, Lee, Juyoung, Chae, Hwajin, Han, Gyeongmin, Kim, Shin-Woo“…In the pre-intervention and post-intervention periods, 4146 patents had one more short-term CVC. In the multivariate logistic regression analyses, multimodal intervention was one of determinants reducing CLABSI rates (odds ratio (OR), 0.52 [95% confidence interval {CI}, 0.28–0.94]). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9148por Xiao, Xian, Zhang, Guixing, Sun, Binxu, Wang, Chaoran, Wang, Xiaoqun, Kong, Fanming, Jia, Yingjie“…Several biosimilars of bevacizumab have been developed and marketed with the expiration of bevacizumab’s patent. The objective of this study was to collate available data from head-to-head randomized controlled trials (RCTs) and evaluate the efficacy and safety of biosimilar bevacizumab compared with the bevacizumab (Avastin(®)) in patients with non-squamous non-small cell lung cancer (NSCLC). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9149por Farag, Marwa Mohamed, Gouda, Mohamed Hazem, Almohsen, Ali Mohamed Abd, Khalifa, Mohammed Attia“…Admission RSS and LVO are the strongest factors affecting SVCF. Maternal anemia, patent ductus arteriosus size (mm/kg), and capillary refill time were significantly associated with high ACA-RI. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9150“…INTRODUCTION: Anxiety in patients undergoing Magnetic resonance imaging (MRI) examinations has been well documented along with causes and strategies to support patent through this. During the Covid-19 pandemic, mask wearing in clinical settings became compulsory for both staff and patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9151“…At a mean follow-up of 3.75 months, computed tomography (CTA) images confirmed that each branch stent remained patent. There were no signs of endoleaks, migrative manifestations, or the need for secondary endovascular intervention or conversion to open surgical procedures. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9152“…Monga’s research interests include network virtualization, software-defined networking, grid/cloud computing and sensor networking, and he holds 17 granted patents. His work experience in the private sector has included software development, research and network engineering for Wellfleet Communications and Nortel, where he focused on application and network convergence. …”
Enlace del recurso
-
9153por Freire Boullosa, Laurie, Van Loenhout, Jinthe, Flieswasser, Tal, Hermans, Christophe, Merlin, Céline, Lau, Ho Wa, Marcq, Elly, Verschuuren, Marlies, De Vos, Winnok H., Lardon, Filip, Smits, Evelien L. J., Deben, Christophe“…Auranofin (AF) is a potent, off-patent thioredoxin reductase (TrxR) inhibitor that efficiently targets cancer via reactive oxygen species (ROS)- and DNA damage-mediated cell death. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9154“…A multivariate logistic regression model revealed that a high positive end-expiratory pressure (PEEP) setting (OR: 2.105; 95% CI: 1.472–3.011; p < 0.001) in established BPD and surgical closure of patent ductus arteriosus (PDA; OR: 6.273; 95% CI: 1.574–24.977; p = 0.009) were associated with BPD–PH. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9155por Jiang, Juan, Gao, Jie, Zhang, Xiuzhen, Li, Yuanmin, Dang, Heqin, Liu, Yanlin, Chen, Wenwen“…CONCLUSIONS: The combined use of sacubitril/valsartan and dapagliflozin was associated with improved cardiac function in patents with HFrEF, and led to greater reductions in LAD and NT-proBNP levels compared to sacubitril/valsartan monotherapy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9156por Onorato, Eustaquio Maria, Grancini, Luca, Monizzi, Giovanni, Mastrangelo, Angelo, Fabbiocchi, Franco, Bartorelli, Antonio L.“…BACKGROUND: Percutaneous suture-mediated patent foramen ovale (PFO) closure has recently been used with the aim of avoiding double-disc nitinol device implantation. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9157“…Patients’ gender, gestational age at birth, age and weight at surgery, side of IH at diagnosis, per-operative findings (presence of contralateral patent processus vaginalis (CPPV)), surgical time, time under anaesthesia, follow-up time, and follow-up findings were collected from an electronic database and analysed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9158por Li, Feng, Shen, Qunshan, Deng, Xiaoxian, Yan, Menghuan, Zheng, Xuan, Zhang, Gangcheng“…CONCLUSIONS: The 10% BAS would be suggested in c-TCD as it addressed larger RLS by increasing the number and stability of microbubbles, and it improves the diagnosis of patent foramen ovale (PFO).…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9159“…BACKGROUND: Transcatheter closure of atrial septal defect (ASD) and patent foramen ovale (PFO) is an established practice, and it requires monitoring and guidance. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9160por Chiba, T, Kajiyama, T, Komai, Y, Takanashi, Y, Yoshino, Y, Ryuzaki, S, Kitagawa, M, Ito, R, Nakano, M, Nakano, M, Kondo, Y, Kobayashi, Y“…In multivariate analysis, recovered RVFAC was related to decrease of appropriate ICD therapy rather than recovered LVEF. In patents without LV dysfunction, recovered RVFAC was significantly associated with lower incidence of ICD therapy (P=0.023, Fig.2) CONCLUSION: RVFAC and RV function improvement may be important to stratify the prognosis of ICD patients. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto